Receptos

Celgene Corporation (CELG) Inks Deal to Buy Receptos (RCPT) for $7.2B

Celgene Corporation (NASDAQ: CELG) signed a definitive agreement to acquire Receptos (NASDAQ: RCPT) for $232 per share or a total of approximately $7.2 billion. The stock price of Celgene closed $122.85 per share, up by more...

Recent posts

Popular categories